BibTex RIS Cite

-

Year 2015, Volume: 5 Issue: 2, 85 - 88, 16.07.2015

Lisa Grimaud Josephine Bigeni Matthew Balbi Nina Nestorova Walter Busuttil Tonio Piscopo

https://doi.org/10.5799/ahinjs.02.2015.02.0182

Abstract

Parçalara ayrılmış implante edilebilir damar yolu açma aparatı enfeksiyonunu takip eden bir Staphylococcus lugdunensis Staphylococcus lugdunensis bakteriyemisi olgusunu bildirdik. Bu olguda özellikle protez cihaz kullanan immünitesi baskılanmış hastalarda gelişen S. lugdunensis’in virulansı vurgulamakla birlikte bu mikroorganizmanın kandan izole edildiğinde kontaminasyon/enfeksiyonunu ayırımının önemine dikkat çekildi. İhtiyaç kalmadığında damar yolu açma aparatlarının hemen çıkarılmasının kateter enfeksiyonlarının önlenmesinde arz ettiği önem ayrıca belirtildi

Keywords

Staphylococcus lugdunensis bakteriyemi damar yolu açma aparatı

References

  • Choi S, Chung J, Lee EJ, et al. Incidence, Characteristics, and outcomes of Staphylococcus lugdunensis bacteraemia. J Clin Microb 2010;48:3346-3349.
  • Babu E, Oropello J. Staphylococcus lugdunensis: The coagulase
  • negative staphylococcus you don’t want to ignore. Expert review of anti-infective therapy. 2011;9:901-907.
  • Frank KL, del Pozo J, Patel R. From clinical microbiology to infection pathogenesis: How daring to be different works for Staphylococcus lugdunensis. Clin Microbiology Review 2008;21:111-33.
  • Herchline T, Ayers L. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiology 1991;29:419-421.
  • Freney J, Brun Y, Bes M, et al. Staphylococcus lugdunensis sp.nov. and Staphylococcus schleiferi sp.nov., Two Species from Human Clincal Specimens. Int J System Evolution Microbiol 1988;38:168-172.
  • Royle T, Davies R, Gannon M. Totally implantable vascular access device-20 years’ experience of implantation in cystic fibrosis patients. Ann R Coll Surg Engl 2008;90:679-684.
  • Di Carlo I, Biffi R. Totally Implantable Venous Access Devices: Management in Mid- and Long-term Clinical Setting. Italia: Springer-Verlag, 2012:201-204.
  • Elzi L, Babouee B, Vogeli N, et al. How to discriminate contamination
  • from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. Clin Microbiol Infect 2012;18:E355-E361.
  • Rahkonen M, Luttinen M, Koskela. True bacteramias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants. Eur J Clin Microbiol Infect Dis 2012;31:2659-2644.

Staphylococcus lugdunensis bacteraemia secondary to an infected intracardiac fragment of a vascular access device

Year 2015, Volume: 5 Issue: 2, 85 - 88, 16.07.2015

Lisa Grimaud Josephine Bigeni Matthew Balbi Nina Nestorova Walter Busuttil Tonio Piscopo

https://doi.org/10.5799/ahinjs.02.2015.02.0182

Abstract

We report a case of Staphylococcus lugdunensis bacteraemia following infection of a fragmented totally implantable vascular access device. This report highlights the virulence of S. lugdunensis especially in immunosuppressed patients with prosthetic devices as well as the importance of distinguishing between contamination and blood stream infection when this organism is cultured from blood. The importance of prompt removal of implantable vascular access devices when they are no longer required, to prevent catheter related infections is also reflected in this report. J Microbiol Infect Dis 2015;5(2): 85-88

Key words: Staphylococcus lugdunensis, bacteraemia, vascular access devices.

Keywords

Staphylococcus lugdunensis bacteraemia vascular access devices

References

  • Choi S, Chung J, Lee EJ, et al. Incidence, Characteristics, and outcomes of Staphylococcus lugdunensis bacteraemia. J Clin Microb 2010;48:3346-3349.
  • Babu E, Oropello J. Staphylococcus lugdunensis: The coagulase
  • negative staphylococcus you don’t want to ignore. Expert review of anti-infective therapy. 2011;9:901-907.
  • Frank KL, del Pozo J, Patel R. From clinical microbiology to infection pathogenesis: How daring to be different works for Staphylococcus lugdunensis. Clin Microbiology Review 2008;21:111-33.
  • Herchline T, Ayers L. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiology 1991;29:419-421.
  • Freney J, Brun Y, Bes M, et al. Staphylococcus lugdunensis sp.nov. and Staphylococcus schleiferi sp.nov., Two Species from Human Clincal Specimens. Int J System Evolution Microbiol 1988;38:168-172.
  • Royle T, Davies R, Gannon M. Totally implantable vascular access device-20 years’ experience of implantation in cystic fibrosis patients. Ann R Coll Surg Engl 2008;90:679-684.
  • Di Carlo I, Biffi R. Totally Implantable Venous Access Devices: Management in Mid- and Long-term Clinical Setting. Italia: Springer-Verlag, 2012:201-204.
  • Elzi L, Babouee B, Vogeli N, et al. How to discriminate contamination
  • from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. Clin Microbiol Infect 2012;18:E355-E361.
  • Rahkonen M, Luttinen M, Koskela. True bacteramias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants. Eur J Clin Microbiol Infect Dis 2012;31:2659-2644.
There are 11 citations in total.

Details

Primary Language English
Journal Section Case Report
Authors

Lisa Grimaud This is me

Josephine Bigeni This is me

Matthew Balbi This is me

Nina Nestorova This is me

Walter Busuttil This is me

Tonio Piscopo This is me

Publication Date July 16, 2015
Published in Issue Year 2015 Volume: 5 Issue: 2

Cite

APA Grimaud, L., Bigeni, J., Balbi, M., Nestorova, N., et al. (2015). Staphylococcus lugdunensis bacteraemia secondary to an infected intracardiac fragment of a vascular access device. Journal of Microbiology and Infectious Diseases, 5(2), 85-88. https://doi.org/10.5799/ahinjs.02.2015.02.0182
AMA Grimaud L, Bigeni J, Balbi M, Nestorova N, Busuttil W, Piscopo T. Staphylococcus lugdunensis bacteraemia secondary to an infected intracardiac fragment of a vascular access device. J Microbil Infect Dis. July 2015;5(2):85-88. doi:10.5799/ahinjs.02.2015.02.0182
Chicago Grimaud, Lisa, Josephine Bigeni, Matthew Balbi, Nina Nestorova, Walter Busuttil, and Tonio Piscopo. “Staphylococcus Lugdunensis Bacteraemia Secondary to an Infected Intracardiac Fragment of a Vascular Access Device”. Journal of Microbiology and Infectious Diseases 5, no. 2 (July 2015): 85-88. https://doi.org/10.5799/ahinjs.02.2015.02.0182.
EndNote Grimaud L, Bigeni J, Balbi M, Nestorova N, Busuttil W, Piscopo T (July 1, 2015) Staphylococcus lugdunensis bacteraemia secondary to an infected intracardiac fragment of a vascular access device. Journal of Microbiology and Infectious Diseases 5 2 85–88.
IEEE L. Grimaud, J. Bigeni, M. Balbi, N. Nestorova, W. Busuttil, and T. Piscopo, “Staphylococcus lugdunensis bacteraemia secondary to an infected intracardiac fragment of a vascular access device”, J Microbil Infect Dis, vol. 5, no. 2, pp. 85–88, 2015, doi: 10.5799/ahinjs.02.2015.02.0182.
ISNAD Grimaud, Lisa et al. “Staphylococcus Lugdunensis Bacteraemia Secondary to an Infected Intracardiac Fragment of a Vascular Access Device”. Journal of Microbiology and Infectious Diseases 5/2 (July 2015), 85-88. https://doi.org/10.5799/ahinjs.02.2015.02.0182.
JAMA Grimaud L, Bigeni J, Balbi M, Nestorova N, Busuttil W, Piscopo T. Staphylococcus lugdunensis bacteraemia secondary to an infected intracardiac fragment of a vascular access device. J Microbil Infect Dis. 2015;5:85–88.
MLA Grimaud, Lisa et al. “Staphylococcus Lugdunensis Bacteraemia Secondary to an Infected Intracardiac Fragment of a Vascular Access Device”. Journal of Microbiology and Infectious Diseases, vol. 5, no. 2, 2015, pp. 85-88, doi:10.5799/ahinjs.02.2015.02.0182.
Vancouver Grimaud L, Bigeni J, Balbi M, Nestorova N, Busuttil W, Piscopo T. Staphylococcus lugdunensis bacteraemia secondary to an infected intracardiac fragment of a vascular access device. J Microbil Infect Dis. 2015;5(2):85-8.